Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma-Reference-Cited by-同舟云学术

Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma

Published:2017-03-07 Issue:10 Volume:101 Page:1315-1317
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Law Andrew,Lindsley Kristina,Rouse Benjamin,Wormald Richard,Dickersin Kay,Li Tianjing

Funder

National Institute for Health Research

National Eye Institute

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference10 articles.

1. Biomarkers and surrogate endpoints in glaucoma clinical trials;Medeiros;Br J Ophthalmol,2015

2. Outcomes in cochrane systematic reviews addressing four common eye conditions: an evaluation of completeness and comparability;Saldanha;PLoS ONE,2014

3. U.S. Food and Drug Administration: Drugs@FDA. Label Approv. Hist. Kaletra®. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/ (accessed 2 Dec 2015).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report From the National Eye Institute Workshop on Neuro-Ophthalmic Disease Clinical Trial Endpoints: Optic Neuropathies;Investigative Opthalmology & Visual Science;2021-11-30

2. Outcome choice and definition in systematic reviews leads to few eligible studies included in meta-analyses: a case study;BMC Medical Research Methodology;2020-02-11

3. Systematic reviews and randomised controlled trials on open angle glaucoma;Eye;2019-12-03

4. Analysis of a Systematic Review About Blue Light–Filtering Intraocular Lenses for Retinal Protection;JAMA Ophthalmology;2019-06-01

5. Cochrane Eyes and Vision: a perspective introducing Cochrane Corner in Eye;Eye;2019-02-19